Biocon Biologics secures multiple market access agreements in US for Yesintek Ruchika Sharma5 May 2025 12:50 PM ISTYESINTEK is a monoclonal antibody that disrupts IL-12 and IL-23 mediated signaling associated immune mediated diseases.
Impaired Fasting Glucose and Sulfonylureas Raise Heart Risk in Inflammatory Arthritis, reveals study Dr Riya Dave5 May 2025 9:15 AM ISTResearchers have discovered in a new study that impaired fasting glucose (IFG) and sulfonylurea use are independently linked with an enhanced risk of...
Uveitis Shows a Strong Two-Way Link with Psoriatic Arthritis, Not Psoriasis Dr Riya Dave22 April 2025 10:15 PM ISTResearchers have established that uveitis (a severe inflammatory eye disease) is bidirectionally linked to psoriatic arthritis but not with...
Secukinumab reduces bone erosion and prevents enthesiophyte progression in psoriatic arthritis: Study Jacinthlyn Sylvia12 April 2025 1:45 AM ISTA new study published in the journal of Arthritis & Rheumatology found with high-resolution peripheral quantitative CT (HR-pQCT), that individuals...
AI-Powered Deep Learning Tool Accurately Assesses Nail Psoriasis Severity: Research Shows Medha Baranwal28 March 2025 9:00 PM ISTGermany: A team of researchers from Germany developed a deep learning model using a convolutional neural network (CNN) to accurately assess nail...
Generate PMS data to assess patient safety : CDSCO Panel Tells Novartis Healthcare on additional indications of Secukinumab Dr. Divya Colin17 March 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major...
Chronic kidney disease in psoriatic arthritis patients elevates joint damage and NSAIDs use: Study Jacinthlyn Sylvia26 Feb 2025 8:30 PM ISTA comprehensive study published in the journal of BMJ Rheumatic & Musculoskeletal Diseases focused on the prevalence and risk factors of chronic...
Biocon Biologics unveils Yesintek biosimilar to Stelara in US Ruchika Sharma25 Feb 2025 12:31 PM ISTYESINTEK will be available in all the same formulations currently provided by Stelara.
Biocon Biologics Yesintek gets European Commission approval for plaque psoriasis, psoriatic arthritis Ruchika Sharma18 Feb 2025 3:42 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the European...
Johnson and Johnson Gets CDSCO Panel Nod To study Guselkumab in Psoriatic Arthritis Dr. Divya Colin17 Feb 2025 5:00 PM ISTNew Delhi: Pharmaceutical major Johnson and Johnson has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Bariatric Surgery tied to significant decrease in prevalence of rheumatic diseases including osteoarthritis: Study Dr Riya Dave10 Jan 2025 8:30 PM ISTResearchers have determined that metabolic and bariatric surgery (MBS) improves patient outcomes in rheumatic diseases. A recent study was conducted...
Biocon Biologics gets Japenese nod for Psoriasis Vulgaris injection Ustekinumab BS Ruchika Sharma7 Jan 2025 1:15 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the...
